Anti-VEGF therapy - a role in obesity-related breast cancer

Journal article

Open access

Peer reviewed

Nature reviews. Endocrinology, Vol.14(6), pp.329-330

06/2018

PMCID: PMC6497165

PMID: 29695750

Abstract

Breast Neoplasms

Fibroblast Growth Factor 2

Humans

Interleukin-6

Obesity

Vascular Endothelial Growth Factor A

url

https://doi.org/10.1038/s41574-018-0021-5View

Version of Record (VoR) Open

13 Record Views

Title: Anti-VEGF therapy - a role in obesity-related breast cancer
Creators: Coral Omene - Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers University, Robert Wood Johnson Medical School, New Brunswick, NJ, USA. co273@cinj.rutgers.edu
Elisa V Bandera - Division of Population Science, Rutgers Cancer Institute of New Jersey, Rutgers University, Robert Wood Johnson Medical School, New Brunswick, NJ, USA
Publication Details: Nature reviews. Endocrinology, Vol.14(6), pp.329-330
Date published: 06/2018
Grant note: K08 CA172722 / NCI NIH HHS
Academic Unit: Cancer Epidemiology and Health Outcomes; Medical Breast Oncology
Language: English
Resource Type: Journal article
Identifiers: 991031666039804646